Fieldpoint Private Securities’s Thermo Fisher Scientific TMO Stock Holding History

Fieldpoint Private Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$546K	Sell	1,005 -2,646	-72%	-$1.46M	0.16%	142
2022 Q1	$2.16M	Sell	3,651 -779	-18%	-$447K	0.44%	53
2021 Q4	$2.96M	Buy	4,430 +171	+4%	+$107K	0.58%	38
2021 Q3	$2.43M	Buy	4,259 +30	+0.7%	+$16.5K	0.54%	45
2021 Q2	$2.29M	Buy	4,229 +155	+4%	+$73.1K	0.5%	50
2021 Q1	$1.86M	Sell	4,074 -203	-5%	-$96.9K	0.43%	53
2020 Q4	$1.99M	Buy	4,277 +327	+8%	+$153K	0.45%	60
2020 Q3	$1.74M	Buy	3,950 +113	+3%	+$46.7K	0.51%	54
2020 Q2	$1.39M	Buy	3,837 +205	+6%	+$68.7K	0.47%	62
2020 Q1	$1.03M	Buy	3,632 +242	+7%	+$76.3K	0.4%	79
2019 Q4	$1.1M	Hold	3,390	–	–	0.32%	93
2019 Q3	$987K	Sell	3,390 -75	-2%	-$21.5K	0.36%	82
2019 Q2	$1.02M	Buy	3,465 +300	+9%	+$82.6K	0.32%	91
2019 Q1	$866K	Hold	3,165	–	–	0.36%	89
2018 Q4	$708K	Hold	3,165	–	–	0.31%	103
2018 Q3	$773K	Buy	3,165 +375	+13%	+$86.3K	0.29%	103
2018 Q2	$578K	Hold	2,790	–	–	0.22%	115
2018 Q1	$576K	Buy	2,790 +2,510	+896%	+$527K	0.26%	97
2017 Q4	$53K	Buy	+280	New	+$53.6K	0.03%	276

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fieldpoint Private Securities's TMO Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Thermo Fisher Scientific (TMO) stake by 72% in Q2 2022, selling an estimated $1.46M and leaving 1,005 shares worth $546K. The position accounts for 0.16% of the portfolio, ranked #142.

Fieldpoint Private Securities first reported a position in TMO in Q4 2017 and has held it in 19 quarters since. The position peaked at $2.96M in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Fieldpoint Private Securities held 1,005 shares of Thermo Fisher Scientific worth $546K as of Q2 2022.
Fieldpoint Private Securities sold 2,646 Thermo Fisher Scientific shares in Q2 2022, an estimated $1.46M.
Thermo Fisher Scientific made up 0.16% of Fieldpoint Private Securities's portfolio in Q2 2022, its #142 holding.
Fieldpoint Private Securities first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 19 quarters since.
Fieldpoint Private Securities's Thermo Fisher Scientific position peaked at $2.96M in Q4 2021.
2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.